Unknown

Dataset Information

WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.


ABSTRACT:

Background

The WldS mouse mutant ("Wallerian degeneration-slow") delays axonal degeneration in a variety of disorders including in vivo models of Parkinson's disease. The mechanisms underlying WldS -mediated axonal protection are unclear, although many studies have attributed WldS neuroprotection to the NAD+-synthesizing Nmnat1 portion of the fusion protein. Here, we used dissociated dopaminergic cultures to test the hypothesis that catalytically active Nmnat1 protects dopaminergic neurons from toxin-mediated axonal injury.

Results

Using mutant mice and lentiviral transduction of dopaminergic neurons, the present findings demonstrate that WldS but not Nmnat1, Nmnat3, or cytoplasmically-targeted Nmnat1 protects dopamine axons from the parkinsonian mimetic N-methyl-4-phenylpyr

SUBMITTER: Antenor-Dorsey JA 

PROVIDER: S-EPMC3322348 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature